Citation:National Health and Medical Research Council 2005
From Cancer Guidelines Wiki
Citation
National Health and Medical Research Council. Screening to prevent cervical cancer: guidelines for the management of asymptomatic women with screen detected abnormalities. Canberra: NHMRC; 2005.
Critical appraisals
Compare quality appraisals for each clinical question
Cited by
- 11. Management of glandular abnormalities
- 13. Screening after total hysterectomy
- 14. Screening in pregnancy
- 16. Screening in immune-deficient women
- 8. Management of discordant colposcopic impression, histopathology and referral LBC prediction
- 9. Management of histologically confirmed low-grade squamous abnormalities
- Appendix B. Guideline development process
- Appendix J. Safety monitoring of the Renewed cervical screening program
- Cytology and explanation of AMBS 2004 terminology for reporting cervical cytology
- Follow-up after excisional treatment for AIS
- Introduction
- Investigation of cytological glandular abnormalities
- Oncogenic HPV types not 16/18
- Oncogenic HPV types not 16/18 (draft public consultation content)
- Oncogenic HPV types not 16/18 (for 1 February 2020)
- Self-collected vaginal samples
- Self-collected vaginal samples (draft public consultation content)
- Self-collected vaginal samples (for 1 February 2020)